Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate different peptide biomarkers, variations in the microbiome and patterns in the bacterial transcriptome as prognostic or diagnostic biomarkers of VAP.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Region Skane
Collaborators
NCT07052604 · Pneumonia, Ventilator-Associated, Stenotrophomonas Maltophilia, and more
NCT05405491 · Pneumonia, Ventilator-Associated, Pneumonia, Hospital-Acquired, and more
NCT06848010 · Pneumonia, Ventilator-Associated, Mechanical Ventilation
NCT07350122 · Cardiac Surgical Procedures (Postoperative Population), Critical Illness, and more
NCT04215692 · Fluid Overload Pulmonary Edema, Fluid Overload, and more
Vestre Viken
Drammen
Hospital de São Francisco Xavier
Lisbon
Skåne University Hospital, Dept. of Infectious diseases
Lund
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions